1. Home
  2. MMED vs GFF Comparison

MMED vs GFF Comparison

Compare MMED & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$16.92

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Logo Griffon Corporation

GFF

Griffon Corporation

HOLD

Current Price

$91.16

Market Cap

4.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMED
GFF
Founded
1983
1959
Country
United States
United States
Employees
2800
N/A
Industry
Medical/Dental Instruments
Building Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.2B
IPO Year
2026
1994

Fundamental Metrics

Financial Performance
Metric
MMED
GFF
Price
$16.92
$91.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
3
Target Price
$22.56
$105.00
AVG Volume (30 Days)
1.1M
369.7K
Earning Date
06-03-2026
05-06-2026
Dividend Yield
N/A
0.99%
EPS Growth
N/A
N/A
EPS
N/A
1.83
Revenue
N/A
$2,519,926,000.00
Revenue This Year
$15.99
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
N/A
$51.05
Revenue Growth
N/A
N/A
52 Week Low
$10.65
$65.01
52 Week High
$17.86
$98.37

Technical Indicators

Market Signals
Indicator
MMED
GFF
Relative Strength Index (RSI) 66.38 49.58
Support Level $14.70 $88.43
Resistance Level N/A $96.58
Average True Range (ATR) 0.92 2.71
MACD 0.07 -0.37
Stochastic Oscillator 89.16 26.98

Price Performance

Historical Comparison
MMED
GFF

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

About GFF Griffon Corporation

Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.

Share on Social Networks: